Effects of Neurofeedback Versus Stimulant Medication in Attention-Deficit/Hyperactivity Disorder: A Randomized Pilot Study
Authors:
Open Access
- 1 September 2013
- journal article
- research article
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 23 (7) , 448-457
Abstract
Objective: The purpose of this pilot study was to compare the effects of 30 sessions of neurofeedback (NF) with stimulant medication on attention-deficit/hyperactivity disorder (ADHD) patients. Methods: Thirty-two medication-naïve ADHD patients, ages 7–16, from a neuropsychiatric clinic, were randomized to NF ( n =16) or drug treatment ( n =16). Other actions, such as parent management training, information, or support in school were given as needed, with no differences between the groups. All participants were assessed before treatment on two rating scales, each with parent and teacher forms. In addition, quantitative electroencephalogram (QEEG) and event-related potentials (ERPs), which included behavioral data from a go/no go test were administered. NF training took place in the clinic over a period of 7–11 months, and was followed by a repeat of the same assessment tools. The mean time interval between pre- and postassesment was not significantly different in the two groups. The 18 symptoms of ADHD (American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders , 4th ed. (DSM-IV)) were used as the primary outcome measure. Results: Analysis of covariance revealed a significant difference between the groups at evaluation in favor of medication, with a large effect size. This picture was confirmed by other outcome measures. The QEEG spectral power in the theta and beta bands did not change in either group. In ERP, the P3 no go component increased significantly in 8 of 12 patients who had a clinically relevant medication effect, but did not increase in the medication nonresponders or the NF group. Conclusions: Our study supports effects for stimulants, but not for NF. Effects of NF may require thorough patient selection, frequent training sessions, a system for excluding nonresponders, and active transfer training. The P3 no go ERP component may be a marker for treatment response.Keywords
This publication has 51 references indexed in Scilit:
- The Effects of QEEG-Informed Neurofeedback in ADHD: An Open-Label Pilot StudyApplied Psychophysiology and Biofeedback, 2012
- ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility studyJournal of Neural Transmission, 2010
- Classification of ADHD patients on the basis of independent ERP components using a machine learning systemNonlinear Biomedical Physics, 2010
- A Meta-analysis of Quantitative EEG Power Associated With Attention-Deficit Hyperactivity DisorderJournal Of Clinical Neurophysiology, 2006
- Long-acting medications for the hyperkinetic disordersEuropean Child & Adolescent Psychiatry, 2006
- Co?existing disorders in ADHD ? implications for diagnosis and interventionEuropean Child & Adolescent Psychiatry, 2004
- European clinical guidelines for hyperkinetic disorder ? first upgradeEuropean Child & Adolescent Psychiatry, 2004
- The development of a quantitative electroencephalographic scanning process for attention deficit-hyperactivity disorder: Reliability and validity studies.Neuropsychology, 2001
- TEST REVIEW Behavior Rating Inventory of Executive FunctionChild Neuropsychology, 2000
- Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T.O.V.A. scores, behavioral ratings, and WISC-R performanceApplied Psychophysiology and Biofeedback, 1995